TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 11, Iss. 7, 2005-03 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL): A Potential Candidate for Combined Treatment of Hematological Malignancies

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3673-3681

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines

By Sonnemann Jürgen   Gänge Jennifer   Kumar K.   Müller Cornelia   Bader Peter   Beck James  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 99-109

Springer Publishing Company

Access to resources Recommend Favorite

Doxorubicin Sensitizes the Non-Small Cell Lung Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated (TRAIL) Apoptosis In Vitro but not In Vivo

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 9, 2011-11 ,pp. : 861-867

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of inducing molecules

By Ingolia T.D.   Platika D.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 847-856

Informa Healthcare

Access to resources Recommend Favorite